uric acid has been researched along with fenofibrate in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (10.87) | 18.7374 |
| 1990's | 5 (10.87) | 18.2507 |
| 2000's | 21 (45.65) | 29.6817 |
| 2010's | 11 (23.91) | 24.3611 |
| 2020's | 4 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Seidehamel, RJ | 1 |
| Bastow, MD; Durrington, PN; Ishola, M | 1 |
| Drouin, P; Morin, C; Panek, E; Siest, G; Steinmetz, J | 1 |
| Desager, JP; Harvengt, C; Heller, F | 1 |
| Ducobu, J | 1 |
| Gathof, BS; Gresser, U; Gross, M | 1 |
| Achard, JM; el Esper, N; Fournier, A; Hottelart, C; Pruna, A | 1 |
| Bairaktari, E; Elisaf, M; Siamopoulos, KC; Tsimichodimos, V | 1 |
| Cadarso, C; de la Serna, G | 1 |
| Bairaktari, ET; Elisaf, MS; Liamis, G | 1 |
| Blane, G; Idzior-Walus, B; Kawalec, E; Rostworowski, W; Sieradzki, J; Wójcik, J; Zarnecki, A; Zdzienicka, A | 1 |
| Elisaf, MS; Milionis, HJ | 1 |
| Hada, T; Moriwaki, Y; Takahashi, S; Tsutsumi, Z; Yamamoto, T | 1 |
| Elisaf, MS; Kiortsis, DN | 1 |
| Achimastos, A; Bairaktari, E; Elisaf, M; Liberopoulos, E; Miltiadous, G; Nikas, S; Tsimihodimos, V | 1 |
| Ball, SG; Feher, MD; Hepburn, AL; Hogarth, MB; Kaye, SA | 1 |
| Feher, MD; Hepburn, AL; Kaye, SA | 1 |
| Ceska, R; Grauova, B; Haas, T; Hradec, J; Kozich, V; Krijt, J; Malik, J; Melenovsky, V; Stulc, T; Wichterle, D | 1 |
| Chasiotis, G; Elisaf, MS; Kakafika, A; Milionis, HJ; Papakostas, J; Seferiadis, K | 1 |
| Feher, MD; Hepburn, AL | 1 |
| Fuse, M; Noguchi, Y; Otsuka, Y; Saito, Y; Shibata, T; Suyama, K; Takeo, C; Tatsuno, I; Yoshida, T | 1 |
| Cicero, AF; Derosa, G; Gaddi, A; Laghi, L; Miconi, A; Nascetti, S | 2 |
| Altuntas, Y; Basat, O; Seber, S; Ucak, S | 1 |
| Daskalopoulou, SS; Elisaf, M; Mikhailidis, DP; Tzovaras, V | 1 |
| Inokuchi, T; Ka, T; Moriwaki, Y; Takahashi, S; Tsutsumi, Z; Yamamoto, T | 1 |
| Lee, CH; Lee, J; Lee, YH | 1 |
| Perez-Ruiz, F | 1 |
| Inokuchi, T; Ka, T; Kobayashi, T; Moriwaki, Y; Takahashi, S; Tsutsumi, Z; Yamamoto, T | 1 |
| Hisatome, I; Igawa, O; Ogino, K | 1 |
| Chen, H; Li, LJ; Luo, Y; Ren, JY; Wang, L | 1 |
| Endou, H; Hosoya, T; Ichida, K; Ohno, I; Saikawa, H; Uetake, D; Yamaguchi, Y | 1 |
| Novikova, IM; Sharashkina, NV; Tkacheva, ON; Torshkhoeva, KhM | 1 |
| Carmona, L; Herrero-Beites, AM; Perez-Ruiz, F | 1 |
| Dohmen, K; Haruno, M; Tanaka, H | 1 |
| Elisaf, M; Kei, A; Liberopoulos, E; Tellis, C; Tselepis, A | 1 |
| Kirch, W; Saar, J | 1 |
| Elshazly, SM; Mahmoud, AA | 1 |
| Akhtar, SS; Balakumar, P; Dhanaraj, SA; Nyo, YH; Oh, AN; Raaginey, D; Renushia, R; Rupeshkumar, M; Sundram, K; Varatharajan, R | 1 |
| Derosa, G; Maffioli, P; Sahebkar, A | 1 |
| Ansquer, JC; Best, JD; Buizen, L; d'Emden, MC; Davis, TME; Feher, MD; Flack, J; Foucher, C; Gebski, V; Hedley, J; Jenkins, AJ; Keech, AC; Kesaniemi, YA; Li, L; McGill, N; Scott, RS; Sullivan, DR; Waldman, B | 1 |
| Choi, Y; Jung, JY; Kim, HA; Suh, CH; Yoon, D | 1 |
| Aryal, N; Cao, JY; Gebski, V; Jenkins, AJ; Keech, AC; Marschner, I; McGill, N; O'Connell, R; Scott, RS; Simes, JR; Sullivan, DR; Taskinen, MR; Waldman, B | 1 |
| Liu, J; Sun, X; Wang, G | 1 |
| Chen, Y; Cheng, X; Cui, L; Han, L; He, Y; Ji, A; Ji, X; Li, C; Li, H; Li, X; Liu, Z; Lu, J; Ma, L; Merriman, TR; Ren, W; Sun, W; Wang, C; Wang, X; Yuan, X; Zhang, H | 1 |
| Chen, Y; Dong, Z; Ji, X; Li, C; Li, R; Lu, J; Zhang, J; Zhao, Y | 1 |
4 review(s) available for uric acid and fenofibrate
| Article | Year |
|---|---|
Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Fenofibrate; Heptanoic Acids; Humans; Losartan; Pyrroles; Uric Acid | 2005 |
[Other antihyperuricemic agents].
Topics: Antihypertensive Agents; Cardiovascular Diseases; Drug Therapy, Combination; Fenofibrate; Gout; Gout Suppressants; Humans; Hyperlipidemias; Hypertension; Hyperuricemia; Hypolipidemic Agents; Losartan; Uric Acid | 2008 |
Plasma uric acid concentrations are reduced by fenofibrate: A systematic review and meta-analysis of randomized placebo-controlled trials.
Topics: C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Fenofibrate; Humans; Randomized Controlled Trials as Topic; Uric Acid | 2015 |
Impact of fenofibrate therapy on serum uric acid concentrations: a review and meta-analysis.
Topics: Fenofibrate; Humans; Hypertriglyceridemia; Treatment Outcome; Uric Acid | 2021 |
20 trial(s) available for uric acid and fenofibrate
| Article | Year |
|---|---|
Fenofibrate in type IV and type V hyperlipoproteinemia.
Topics: Cholesterol; Double-Blind Method; Female; Fenofibrate; Gastrointestinal Diseases; Humans; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Male; Middle Aged; Multicenter Studies as Topic; Propionates; Triglycerides; Uric Acid | 1989 |
Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial.
Topics: Bezafibrate; Clinical Trials as Topic; Dietary Carbohydrates; Double-Blind Method; Fenofibrate; Fructose; Humans; Lipoproteins; Male; Propionates; Triglycerides; Uric Acid | 1988 |
Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.
Topics: Adult; Fenofibrate; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipids; Middle Aged; Propionates; Transaminases; Uric Acid; Uricosuric Agents | 1980 |
[Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency].
Topics: Aged; Creatinine; Cross-Over Studies; Female; Fenofibrate; Glomerular Filtration Rate; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Inulin; Kidney Failure, Chronic; Kidney Tubules; Male; Middle Aged; Natriuresis; p-Aminohippuric Acid; Prospective Studies; Renal Circulation; Urea; Uric Acid | 1999 |
Fenofibrate decreases plasma fibrinogen, improves lipid profile, and reduces uricemia.
Topics: Aged; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fenofibrate; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Treatment Outcome; Triglycerides; Uric Acid | 1999 |
Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Blood Glucose; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Creatine Kinase; Fasting; Fenofibrate; gamma-Glutamyltransferase; Glucose Tolerance Test; Hemostasis; Humans; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Uric Acid | 2000 |
Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol.
Topics: Adult; Allopurinol; Cholesterol; Creatinine; Drug Interactions; Fenofibrate; Gout Suppressants; Humans; Hypolipidemic Agents; Hypoxanthine; Male; Oxypurinol; Purines; Triglycerides; Uric Acid; Xanthine | 2001 |
Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.
Topics: Acute Disease; Adult; Aged; Alkaline Phosphatase; Allopurinol; Arthritis, Gouty; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Fenofibrate; Gout; Gout Suppressants; Humans; Hyperuricemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Recurrence; Uric Acid | 2003 |
Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.
Topics: Cholesterol; Creatinine; Cysteine; Female; Fenofibrate; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Prospective Studies; Statistics as Topic; Triglycerides; Uric Acid | 2003 |
Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
Topics: Analysis of Variance; Atorvastatin; Blood Glucose; Female; Fenofibrate; Heptanoic Acids; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Simvastatin; Uric Acid | 2003 |
Effect of fenofibrate on uric acid metabolism in Japanese hyperlipidemic patients.
Topics: Adult; Aged; Female; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Japan; Male; Middle Aged; Uric Acid | 2004 |
Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates.
Topics: Adult; Blood Pressure; Cholesterol; Coenzymes; Creatinine; Drug Resistance; Drug Therapy, Combination; Fatty Acids, Unsaturated; Female; Fenofibrate; gamma-Glutamyltransferase; Humans; Hypertriglyceridemia; Lipoprotein(a); Male; Middle Aged; Time Factors; Treatment Outcome; Triglycerides; Ubiquinone; Uric Acid | 2005 |
The effect of dual PPAR alpha/gamma stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyslipidemias; Fenofibrate; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Lipid Metabolism; Middle Aged; PPAR alpha; PPAR gamma; Prospective Studies; Rosiglitazone; Thiazolidinediones; Triglycerides; Uric Acid | 2006 |
Effects of a fenofibrate/losartan combination on the plasma concentration and urinary excretion of purine bases.
Topics: Adult; Antihypertensive Agents; Cholesterol; Dose-Response Relationship, Drug; Fenofibrate; Humans; Hypolipidemic Agents; Hypoxanthine; Losartan; Male; Metabolic Clearance Rate; Middle Aged; Time Factors; Triglycerides; Uric Acid; Xanthine | 2006 |
Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH.
Topics: Bezafibrate; Biomarkers; Body Mass Index; Fenofibrate; Gout; Humans; Hydrogen-Ion Concentration; Hypolipidemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Nephrolithiasis; PPAR alpha; Regression Analysis; Triglycerides; Uric Acid | 2007 |
[Effects of micronized fenofibrate on lipid and uric acid metabolism in patients with hyperlipidemia].
Topics: Adult; Aged; Female; Fenofibrate; Humans; Hyperlipidemias; Hyperuricemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Triglycerides; Uric Acid | 2009 |
Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.
Topics: Aged; Apolipoprotein B-100; Atorvastatin; Bilirubin; Biomarkers; Dinoprost; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Fluorobenzenes; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Lipoproteins, LDL; Male; Middle Aged; Niacin; Oxidative Stress; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors; Treatment Outcome; Uric Acid | 2014 |
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study.
Topics: Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fenofibrate; Gout; Humans; Hypolipidemic Agents; Male; Middle Aged; Risk Reduction Behavior; Treatment Outcome; Uric Acid | 2018 |
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study.
Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fenofibrate; Heart Disease Risk Factors; Humans; Hypolipidemic Agents; Risk Factors; Uric Acid | 2020 |
Fenofibrate decreased microalbuminuria in the type 2 diabetes patients with hypertriglyceridemia.
Topics: Adult; Aged; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fenofibrate; Glomerular Filtration Rate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Kidney; Male; Middle Aged; Triglycerides; Uric Acid | 2020 |
22 other study(ies) available for uric acid and fenofibrate
| Article | Year |
|---|---|
Biological variations in hyperlipidemic children and adolescents treated with fenofibrate.
Topics: Adolescent; Adult; Alkaline Phosphatase; Bilirubin; Child; Child, Preschool; Cholesterol; Fenofibrate; gamma-Glutamyltransferase; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Propionates; Transaminases; Triglycerides; Uric Acid | 1981 |
[Clinical study of fenofibrate in hyperlipoproteinemias].
Topics: Adult; Aged; Cholesterol; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipids; Male; Middle Aged; Propionates; Triglycerides; Uric Acid | 1980 |
Benzbromarone and fenofibrate are lipid lowering and uricosuric: a possible key to metabolic syndrome?
Topics: Benzbromarone; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Fenofibrate; Gout; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney; Kinetics; Syndrome; Uric Acid; Uricosuric Agents | 1994 |
Effect of micronized fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia.
Topics: Adult; Aged; Antihypertensive Agents; Blood Chemical Analysis; Female; Fenofibrate; Humans; Hypertension; Hypolipidemic Agents; Losartan; Male; Middle Aged; Polypharmacy; Uric Acid | 1999 |
Effect of fenofibrate on serum uric acid levels.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Uric Acid | 1999 |
Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: case histories.
Topics: Antihypertensive Agents; Arteriosclerosis; Benzothiadiazines; Diuretics; Female; Fenofibrate; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Losartan; Male; Middle Aged; Risk Factors; Sodium Chloride Symporter Inhibitors; Uric Acid | 2000 |
Serum uric acid levels: a useful but not absolute marker of compliance with fenofibrate treatment.
Topics: Adult; Aged; Biomarkers; Female; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Patient Compliance; Uric Acid | 2001 |
The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamide.
Topics: Adult; Aged; Antihypertensive Agents; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Indapamide; Male; Middle Aged; Triglycerides; Uric Acid | 2002 |
Long-term remission from gout associated with fenofibrate therapy.
Topics: Fenofibrate; Gout; Humans; Hyperlipidemias; Hyperuricemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Remission Induction; Time Factors; Uric Acid | 2003 |
Gout.
Topics: Coronary Disease; Fenofibrate; Gout; Humans; Hypolipidemic Agents; Metabolic Syndrome; Risk Factors; Uric Acid | 2004 |
Treatment of massive hypertriglyceridemia resistant to PUFA and fibrates: a possible role for the coenzyme Q10?
Topics: Adult; Blood Pressure; Cholesterol; Coenzymes; Creatinine; Diet; Drug Resistance; Fatty Acids, Omega-3; Female; Fenofibrate; gamma-Glutamyltransferase; Humans; Hypertriglyceridemia; Lipoprotein(a); Male; Middle Aged; Triglycerides; Ubiquinone; Uric Acid | 2005 |
Effect of fenofibrate in combination with urate lowering agents in patients with gout.
Topics: Adult; Aged; Fenofibrate; Gout; Humans; Lipids; Male; Middle Aged; Uric Acid; Uricosuric Agents | 2006 |
New treatments for gout.
Topics: Allopurinol; Ascorbic Acid; Female; Fenofibrate; Gout; Gout Suppressants; Humans; Losartan; Male; Sensitivity and Specificity; Urate Oxidase; Uric Acid | 2007 |
Effect of fenofibrate on uric acid metabolism and urate transporter 1.
Topics: Adult; Cell Line; Fenofibrate; Humans; Male; Organic Anion Transporters; Organic Cation Transport Proteins; Uric Acid | 2010 |
[Lipid lowering, antiinflammatory, and vasoprotective effects of fenofibrate in patients with type 2 diabetes mellitus].
Topics: Adult; Aged; C-Reactive Protein; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Female; Fenofibrate; Humans; Hypolipidemic Agents; Male; Middle Aged; Patient Selection; Time Factors; Uric Acid; Vasodilation | 2010 |
A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.
Topics: Aged; Cohort Studies; Colchicine; Crystallization; Female; Fenofibrate; Follow-Up Studies; Gout; Gout Suppressants; Humans; Hyperuricemia; Kaplan-Meier Estimate; Losartan; Male; Middle Aged; Prospective Studies; Regression Analysis; Secondary Prevention; Time Factors; Treatment Outcome; Uric Acid; Withholding Treatment | 2011 |
Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis.
Topics: Adult; Aged; Asymptomatic Diseases; Bezafibrate; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; PPAR alpha; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Uric Acid; Ursodeoxycholic Acid | 2013 |
[A new application for well-known pharmaceutics--losartan and fenofibrate as potential remedies against gout?].
Topics: Angiotensin II Type 1 Receptor Blockers; Fenofibrate; Gout; Gout Suppressants; Humans; Hypolipidemic Agents; Losartan; Off-Label Use; Treatment Outcome; Uric Acid | 2014 |
Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Fenofibrate; Fructose; Glutathione; Glycation End Products, Advanced; Insulin; Insulin Resistance; Male; Malondialdehyde; Metabolic Syndrome; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Wistar; Triglycerides; Uric Acid; Ursodeoxycholic Acid | 2014 |
Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.
Topics: Animals; Blood Glucose; Cholesterol; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dipyridamole; Drug Therapy, Combination; Fenofibrate; Kidney; Lipoproteins, HDL; Lisinopril; Male; Organ Size; Protective Agents; Rats, Sprague-Dawley; Triglycerides; Urea; Uric Acid | 2014 |
Effect of fenofibrate on uric acid level in patients with gout.
Topics: Adult; Aged; Drug Interactions; Enzyme Inhibitors; Female; Fenofibrate; Gout; Humans; Kidney; Liver; Male; Middle Aged; Uric Acid; Xanthine Oxidase | 2018 |
Effects of fenofibrate therapy on renal function in primary gout patients.
Topics: Creatinine; Drug Monitoring; Electronic Health Records; Female; Fenofibrate; Gout; Humans; Hypolipidemic Agents; Kidney Diseases; Male; Middle Aged; Outcome Assessment, Health Care; Risk Assessment; Risk Factors; Triglycerides; Uric Acid | 2021 |